ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts

JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control and registration.

Great value, highly-relevant meetings presented by recognised leading experts in their field
Powerful networking opportunities
Superb and highly convenient locations
Non-profit professional organisation means lower delegate fees

Our only sponsors are our parent professional bodies, the Royal Pharmaceutical Society and the Royal Society of Chemistry.

  • 00
  •  days  
  • 00
  •  hours  
  • 00
  •  minutes  
  • 00
  •  seconds  
16th October 2014
How similar must biosimilars be?
Royal Society of Chemistry, Burlington House, Piccadilly, London W1J 0BA
The analytical characterisation undertaken to support quality assessment of a biosimilar is identical to that required for any novel biopharmaceutical product but with a very important additional requirement – the need for a very comprehensive comparison with a licensed reference product.
If you are working with biopharmaceuticals, do you understand why this is so? What are the key factors that can differ between a biosimilar and an originator product? Why do the characterisation methods often differ? What effects do these differences have on the safety and efficacy of the biosimilar product?
Are you aware of the FDA draft guidance on "Scientific Considerations in Demonstrating Biosimilarity to a Reference Product" and its relationship to EMA guidance?
This symposium will identify and review the process of bringing these types of product to market and show how comparability needs to be demonstrated to gain regulatory approval. If your work involves the quality of biopharmaceuticals - and particularly if you are a QP – this is an event you must not miss.

11th December 2014
Stability challenges Part II: Assuring the stability of medicines from manufacture to clinical use
Royal Society of Chemistry, London
This symposium examines best practice during the distribution and storage of medicines, to ensure correct storage conditions are maintained and to ensure the quality of the medicine is maintained during use in the clinic or by the patient. The generation of data to support temperature excursions and to demonstrate in-use stability will be explored.

5th February 2015
Quality Risk Management: a pragmatic approach
GlaxoSmithKline, Ware
An effective quality risk management (QRM) process provides a key mechanism for the proactive identification and control of potential issues that may arise during product development and subsequent commercialisation (ICH Q9).
Scientific approaches are used to estimate the likelihood of any given risk.
This symposium will look at the assessment of risk from an academic, regulatory and industrial perspective and will cover method development, specification setting, chemical purging and genotoxin risk assessment (GRA) using in silico methodologies.

19th March 2015
Combating counterfeit medicines: the solutions
Royal Society of Chemistry, Burlington House, Piccadilly, London W1J 0BA
Sub-standard and counterfeit medicines are a great threat to patient health and safety. They may cause death due to the lack of active drug, as found in some vaccines and antibiotics, or because of the presence of a toxic material, such as the substitution of diethylene glycol for glycerol.

7th September 2014
Combating counterfeit medicines: what pharmacists need to know
International Convention Centre, Birmingham
RPS Annual Conference,
Counterfeit Medicines are a global problem and the Falsified Medicines Directive came into force in January 2013 in an attempt to solve this problem in Europe. This session examines the problems of counterfeit medicines globally with specific reference to the UK and describes the important front line role that pharmacists have in combating this threat to the safety of public health.

8th September 2014
New medicines: future benefits and current analytical challenges
University of Hertfordshire
JPAG symposium session at the APS UKPharmSci Conference. Monday 8th September 2014

This symposium reviews some of the challenges arising from developments of new medicines and therapeutic regimes for the analytical scientist.

30th September 2014
4th Annual MIBio Conference
Downing College, Cambridge University
MIBio 2014 is organised by the Formulation Science and Technology Group (FSTG) of the Royal Society Chemistry (RSC) and the Academy of Pharmaceutical Scientists (APS)
The MIBio conference series aims to engage world leading experts from academia and industry in a discussion in how the latest molecular interaction based discoveries can be exploited in biopharmaceutical formulation to produce more effective and safer therapeutic products.

3rd July 2014
Assuring the quality of medicines
Royal Society of Chemistry, Burlington House, Piccadilly, London W1J 0BA
The quality of the drug substance and the drug product is critical to ensure the safety and efficacy of medicines. If you have any role in ensuring the quality of medicines, do you have all the tools you need to resolve every-day quality issues?
Qualified Persons (QPs) have a critical role in releasing batches of pharmaceutical products. An understanding of the supply chain and manufacturing challenges is an essential component to the conduct of this role. This symposium takes a strategic look at solving everyday quality issues and the changing role of QPs.

APS PharmSci Conference 2014
Monday 8th September
Be sure to attend the JPAG symposium programme on New medicines: future benefits and current analytical challenges
For details see the left-hand panel.
The programme also includes presentations by young researchers competing for the Geoffrey Phillips Analytical Science Award.

How similar must biosimilars be?
Thursday 16 October 2014
Registration is now proceeding

Future programme
Plan ahead to attend the events scheduled for 2015


Good speakers with a real flare and enthusiasm for their work, making the presentations very interesting [March 2012]

Overall it was a useful course and nice connection to the science and the advances in pharmaceutical analysis [March 2012]

The facilities and refreshments/food were EXCELLENT – thank you [May 2012]

Very good symposium – many thanks [May 2012]

This was a very useful meeting with a wide range of interesting presentations [March 2013]

Good venue, good organisation [May 2013]

Most of the speakers made a general and quite useful introduction which allowed everyone to follow the presentation no matter the level; it was really easy to reach the location [May 2013]

I thought the symposium was very well balanced to cover all aspects of stability – hence it was all very useful [July 2013]

Good, well-organised and attended day, relevant presentations, interesting comments and discussion [July 2013]

Excellent venue, very good speakers and overall topics highly applicable [July 2013]

Excellent day; very fruitful discussions with new acquaintances [October 2013]

Venue, facilities and lunch were very good [October 2013]

Good variety of topics and delegates [October 2013]

Length of presentations ideal; catering excellent – thanks [October 2013]

A friendly,informal group of scientists co-ordinated and attended this meeting – makes for an enjoyable experience [February 2014]

A wide-ranging list of topics, good mix of different applications; thank you – very enjoyable and informative, great location [March 2014]

Expert presenters with well-illustrated presentations [May 2014]


Pharmaceutical equivalence, therapeutic equivalence and the role of..
JPAG presents another in a series what has become a regular feature on this page.

The article is entitled "Pharmaceutical equivalence, therapeutic equivalence and the role of analytical science", written by Dr Dave Elder, GlaxoSmithKline, ...
20th August 2014

What does quality mean to you?
JPAG presents the latest in a series what has become a regular feature on this page, helping you keep up to date with current developments in the pharmaceutical industry. "What does quality mean to you?", written by Dr Dave Elder, GSK, member of the ...
4th July 2014

APS Emerging Scientists’ Bright Idea Award 2014
8th - 10th September 2014, University of Hertfordshire, Hatfield
The Academy of Pharmaceutical Scientists Emerging Scientists’ Bright Idea Award 2014

In conjunction with this year’s conference the APS is pleased to announce the Emergi...
1st July 2014

Delegates who have attended any of the JPAG symposia since February 2011 year can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look for MY PAST MEETINGS.

Missed the meeting?
You can access a short report of recent meetings!

Just go to the MEETINGS page, go to PAST MEETINGS 2011-present. Then select the DETAILS for the meeting that interests you.

And do be sure to check the list of upcoming meetings so that you don't miss the next one!

European Pharmaceutical Review

JPAG members can receive a free hard copy subscription to EPR
click here

This site does not use cookies.
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).

Follow us:

© Joint Pharmaceutical Analysis Group 2014
Website by Delta Consultancy Services